Vicodin

Undaunted Vertex closes in on FDA nod for non-opioid pain drug

While other companies gave up on trying to develop a non-opioid pain relief medicine by targeting sodium channel inhibition, Vertex stayed the course.

Kevin Dunleavy Oct 28, 2024 5:00am

positive negative up down good bad mixed

Vertex's phase 3 pain trials hit goals but fail to beat Vicodin

Jan 30, 2024 8:00am